Display options
Share it on

Eur Clin Respir J. 2015 Jul 20;2. doi: 10.3402/ecrj.v2.26375. eCollection 2015.

Reference values for spirometry - report from the Obstructive Lung Disease in Northern Sweden studies.

European clinical respiratory journal

Helena Backman, Anne Lindberg, Anders Odén, Linda Ekerljung, Linnéa Hedman, Annette Kainu, Anssi Sovijärvi, Bo Lundbäck, Eva Rönmark

Affiliations

  1. The OLIN Unit, Division of Occupational and Environmental Medicine, Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
  2. Division of Medicine, Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
  3. Division of Mathematical Sciences, Chalmers University of Technology, Gothenburg, Sweden.
  4. Krefting Research Centre, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden.
  5. HUCH Heart and Lung Center, Peijas Hospital, Helsinki University Central Hospital, Helsinki, Finland.
  6. HUS Medical Imaging Centre, Department of Clinical Physiology and Nuclear Medicine, Helsinki University Central Hospital, Helsinki, Finland.
  7. The OLIN Unit, Division of Occupational and Environmental Medicine, Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden ; Krefting Research Centre, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden.

PMID: 26557250 PMCID: PMC4629723 DOI: 10.3402/ecrj.v2.26375

Abstract

BACKGROUND: Abnormal lung function is commonly identified by comparing observed spirometric values to corresponding reference values. It is recommended that such reference values for spirometry are evaluated and updated frequently. The aim of this study was to estimate new reference values for Swedish adults by fitting a multivariable regression model to a healthy non-smoking general population sample from northern Sweden. Further aims were to evaluate the external validity of the obtained reference values on a contemporary sample from south-western Sweden, and to compare them to the Global Lung Function Initiative (GLI) reference values.

METHOD: Sex-specific multivariable linear regression models were fitted to the spirometric data of n=501 healthy non-smoking adults aged 22-91 years, with age and height as predictors. The models were extended to allow the scatter around the outcome variable to depend on age, and age-dependent spline functions were incorporated into the models to provide a smooth fit over the entire age range. Mean values and lower limits of normal, defined as the lower 5th percentiles, were derived.

RESULT: This modelling approach resulted in unbiased estimates of the spirometric outcomes, and the obtained estimates were appropriate not only for the northern Sweden sample but also for the south-western Sweden sample. On average, the GLI reference values for forced expiratory volume in one second (FEV1) and, in particular, forced expiratory vital capacity (FVC) were lower than both the observed values and the new reference values, but higher for the FEV1/FVC ratio.

CONCLUSION: The evaluation based on the sample of healthy non-smokers from northern Sweden show that the Obstructive Lung Disease in Northern Sweden reference values are valid. Furthermore, the evaluation based on the south-western Sweden sample indicates a high external validity. The comparison with GLI brought further evidence to the consensus that, when available, appropriate local population-specific reference values may be preferred.

Keywords: Z-scores; linear regression; percentiles; reference equations; reference sample; spline functions

References

  1. Allergy Asthma Clin Immunol. 2013 Jun 11;9(1):20 - PubMed
  2. Eur Respir J. 2013 Oct;42(4):1046-54 - PubMed
  3. BMC Pulm Med. 2015 Mar 25;15:26 - PubMed
  4. Respir Med. 2013 Dec;107(12):2000-8 - PubMed
  5. Eur Respir J. 2001 Nov;18(5):770-9 - PubMed
  6. Am J Respir Crit Care Med. 1999 Jan;159(1):179-87 - PubMed
  7. Bull Eur Physiopathol Respir. 1985 Nov-Dec;21(6):551-7 - PubMed
  8. Lancet Respir Med. 2013 Oct;1(8):599-609 - PubMed
  9. Thorax. 2007 Sep;62(9):792-8 - PubMed
  10. Chest. 2015 Mar;147(3):792-7 - PubMed
  11. Am Rev Respir Dis. 1991 Nov;144(5):1202-18 - PubMed
  12. Am J Respir Crit Care Med. 2010 Mar 1;181(5):446-51 - PubMed
  13. Respir Med. 2014 May;108(5):685-93 - PubMed
  14. World Allergy Organ J. 2014 Jan 02;7(1):1 - PubMed
  15. Am Rev Respir Dis. 1983 Jun;127(6):725-34 - PubMed
  16. Thorax. 1991 Sep;46(9):643-50 - PubMed
  17. Eur Respir J. 2005 Nov;26(5):948-68 - PubMed
  18. Eur Respir J. 2005 Aug;26(2):319-38 - PubMed
  19. Bull Eur Physiopathol Respir. 1986 Sep-Oct;22(5):451-9 - PubMed
  20. Eur Respir J. 2011 Mar;37(3):658-64 - PubMed
  21. Scand J Clin Lab Invest Suppl. 1982;159:5-20 - PubMed
  22. Eur Respir J. 2014 Feb;43(2):505-12 - PubMed
  23. Ups J Med Sci. 1986;91(3):299-310 - PubMed
  24. Am J Respir Crit Care Med. 2008 Feb 1;177(3):253-60 - PubMed
  25. Eur Respir J. 2010 Jul;36(1):12-9 - PubMed
  26. Eur Respir J. 2012 Dec;40(6):1324-43 - PubMed
  27. Clin Physiol Funct Imaging. 2016 Sep;36(5):346-58 - PubMed
  28. Eur Respir J Suppl. 1993 Mar;16:5-40 - PubMed
  29. Eur Respir J. 2013 Jun;41(6):1362-70 - PubMed
  30. Respir Investig. 2014 Jul;52(4):242-50 - PubMed
  31. Acta Med Scand. 1963 Feb;173:185-92 - PubMed
  32. Am J Respir Crit Care Med. 2007 Sep 15;176(6):532-55 - PubMed
  33. Stat Med. 1992 Jul;11(10):1305-19 - PubMed
  34. Stat Med. 2009 Feb 28;28(5):880-98 - PubMed
  35. Ann Clin Res. 1986;18(3):160-6 - PubMed
  36. Clin Physiol. 2001 Nov;21(6):648-60 - PubMed
  37. Bull Eur Physiopathol Respir. 1986 Nov-Dec;22(6):589-97 - PubMed
  38. Eur Respir J. 2013 Jun;41(6):1249-51 - PubMed

Publication Types